Bringing the fundamentals into focus…
Back to Genmab A/S
How Genmab A/S stacks up
GMAB · against 74 other Healthcare companies of similar size
Growth
68/ 100
Above the middle of the pack.
Ranked #25 of 75 · scores higher than 65% of peers
Bars: peers in each 10-point band of the growth score8 peers with a growth score of 60–69, including GMAB · Click a bar to see the companies
Why growth scores 68?
Weighted metrics compared with all Healthcare companies.Mainly thanks to its 3-year revenue growth and revenue growth, which are stronger than most Healthcare peers.
- slower growth in earnings per share: weaker than 69% of peers. Earnings per share growth: -9.2% vs peer median 9.8%
- faster revenue growth over the last year: stronger than 77% of peers. Revenue growth: 19.2% vs peer median 6.1%
- faster revenue growth over three years: stronger than 81% of peers. 3-year revenue growth: 21.2% vs peer median 5.8%
Metric by metric
Position: dot = GMAB, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | GMAB | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 76 reported | 19.2% | 10.9% | 79% | 33% | |
| Earnings per share growthHigher is better · 57 reported | -9.2% | 16.6% | 20% | 33% | |
| 3-year revenue growthHigher is better · 75 reported | 21.2% | 9.0% | 89% | 33% |
Ranking by growth score
Top 5 and the companies ranked around GMAB| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 21.4B USD | 97 | 67 | |
| 2 | 56.7B USD | 96 | 79 | |
| 3 | 22.8B USD | 95 | 38 | |
| 4 | 40.2B USD | 92 | 73 | |
| 5 | 138.4B HKD (≈$17.7B) | 91 | 70 | |
| 20 | 45.2B USD | 71 | 46 | |
| 23 | 73.2B SAR (≈$19.8B) | 70 | 56 | |
| 24 | 49.1B USD | 69 | 69 | |
| 25 | 17.9B USD | 68 | 76 | |
| 25 | 34.6B USD | 68 | 58 | |
| 25 | 1.77T INR (≈$21.2B) | 68 | 57 | |
| 28 | 327.3B CNY (≈$45.8B) | 64 | 75 | |
| 29 | 8.24T JPY (≈$56.0B) | 63 | 75 | |
| 30 | 5.26T JPY (≈$35.8B) | 60 | 63 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score